These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20850296)

  • 1. Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial.
    Verleye L; Ottevanger PB; Kristensen GB; Ehlen T; Johnson N; van der Burg ME; Reed NS; Verheijen RH; Gaarenstroom KN; Mosgaard B; Seoane JM; van der Velden J; Lotocki R; van der Graaf W; Penninckx B; Coens C; Stuart G; Vergote I
    Eur J Cancer; 2011 Jan; 47(1):57-64. PubMed ID: 20850296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
    Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
    Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
    Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
    Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant breast cancer reporting: using process measures to improve anatomic pathology reporting.
    Hammond EH; Flinner RL
    Arch Pathol Lab Med; 1997 Nov; 121(11):1171-5. PubMed ID: 9372744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completeness of low anterior resection pathology report: a hospital-based audit with recommendations on improving reporting.
    Nambiar A; Vivek N; Bindu MR; Sudheer OV; Bai L
    Indian J Cancer; 2010; 47(2):156-9. PubMed ID: 20448379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy and ovarian cancer].
    Ray-Coquard I; Saba C; Bachelot T; Méeus P; Mignotte H; Blondet R; Treilleux I; Peix M; Guastalla JP
    Bull Cancer; 2006 Jul; 93(7):669-76. PubMed ID: 16873075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EORTC-GCG process quality indicators for ovarian cancer surgery.
    Verleye L; Ottevanger PB; van der Graaf W; Reed NS; Vergote I;
    Eur J Cancer; 2009 Mar; 45(4):517-26. PubMed ID: 19013789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
    Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology reporting of rectal cancer: a national audit.
    Keating J; Lolohea S; Kenwright D
    N Z Med J; 2003 Jul; 116(1178):U514. PubMed ID: 12897882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Assessment of Synoptic Pathology Reporting for Ovarian Cancer.
    Słodkowska J; Cierniak S; Patera J; Kopik J; Baranowski W; Markiewicz T; Murawski P; Buda I; Kozłowski W
    Pathobiology; 2016; 83(2-3):70-8. PubMed ID: 27100104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
    Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets.
    King PM; Blazeby JM; Gupta J; Alderson D; Moorghen M
    J Clin Pathol; 2004 Jul; 57(7):702-5. PubMed ID: 15220361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
    Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
    Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
    Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
    Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions.
    Nakhleh RE; Jones B; Zarbo RJ
    Arch Pathol Lab Med; 1997 Jan; 121(1):11-8. PubMed ID: 9111087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian cancer].
    Onda T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1735-9. PubMed ID: 18030006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?].
    Morice P; Leblanc E; Narducci F; Pomel C; Pautier P; Chevalier A; Lhommé C; Castaigne D
    Gynecol Obstet Fertil; 2005; 33(1-2):55-63. PubMed ID: 15752668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standards, options and recommendations for the composition of anatomic and surgical pathology reports or cytopathology reports in oncology].
    Arnould L; Fiche M; Blanc-Vincent MP; Le Doussal V; Signal-Zafrani B; Gory-Delaboere G; Briffod M; Vielh P; Voigt JJ;
    Ann Pathol; 2003 Feb; 23(1):79-95. PubMed ID: 12743509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy in ovarian cancer.
    Park TW; Kuhn WC
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):639-47. PubMed ID: 15270667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.